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Abstract
Aim To assess the outcomes of recto-vaginal reinforce-
ment procedures in adults with chronic constipation.
Method Standardised methods and reporting of bene-
fits and harms were used for all CapaCiTY reviews that
closely adhered to PRISMA 2016 guidance. Main con-
clusions were presented as summary evidence statements
with a summative Oxford Centre for Evidence-Based
Medicine (2009) level.
Results Forty-three articles were identified, providing
data on outcomes in 3346 patients. Average length of
procedures ranged between 20 and 169 min, and
length of stay between 1 and 15 days. Complications
typically occurred after 7–17% of procedures (range 0–
61%). Post-operative bleeding was uncommon (0–4%)
as well as haematoma or sepsis (0–2%). Fistulation did
not occur in most studies. Two procedure-related
deaths were observed for 3209 patients. Although
inconsistent, 78% of patients reported a satisfactory or
good outcome, with 30–50% experiencing reduced
symptoms of straining, incomplete emptying or reduced
vaginal digitation. About 17% of patients developed
anatomical recurrence. Considering measures of harm
and global satisfaction rating scales, there was insuffi-
cient evidence to prefer one type of procedure over
another. There was no evidence to support better out-
comes based on selection of patients with a particular
size or grade of rectocoele.
Conclusion Evidence supporting recto-vaginal rein-
forcement procedures is currently derived from observa-
tional studies and comparisons, with only one high
quality study. Large trials are needed to inform future
clinical decision making.
Keywords Recto-vaginal reinforcement, constipation,
rectocele, STARR, transvaginal repair, transanal repair
Introduction
Background and procedural variations
Chronic constipation is related to an inability to evacu-
ate the rectum in over half of all adults presenting for
specialist advice. This phenomenon, which may be vari-
ably described as obstructed defaecation or rectal evacu-
ation disorder (and many other terms), is characterised
by excessive straining, the feeling of incomplete evacua-
tion, post-defaecatory seepage and often mucous dis-
charge, and pelvic pain [1]. In some of these patients
there is clinical and radiological (usually proctographic)
evidence of a dynamic structural abnormality leading to
physical impediment to emptying during defaecation.
By far away, the way most common abnormalities are
rectocoele and/or intussusception.
Traditionally a rectocoele may be considered either a
bulge into the vagina, giving vaginal prolapse symp-
toms, or the sensation of a lump or mass. Also, a herni-
ation of the rectum into the vagina preventing complete
evacuation may lead to ‘trapping’ of faeces in the
‘pocket’ and subsequent incomplete evacuation (bal-
looning may also lead to loss of vector forces along the
anorectal axis). This process can lead to dissatisfaction
with emptying and repeated visits to the toilet, post-
defaecatory soiling and the need to apply pressure to
the posterior vaginal wall or perineum to splint the rec-
tocoele and maximise emptying. Many women will also
‘digitate’ or manually assist emptying using a finger
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either in the rectocoele via the anus to aid with com-
plete emptying or in the vagina to splint against the
posterior vagina to prevent trapping and direct evacua-
tory forces down along the axis of the anus.
It follows that strategies have been employed to
anatomically correct a rectocele by reinforcing the barrier
between the rectum and vagina (rectovaginal septum).
Access for rectovaginal reinforcement varies with three
main approaches described: the posterior vagina (poste-
rior repair [2]), the perineum (transperineal repair [3]),
or via the anus (transanal repair [4,5]). Vaginal repairs all
involve an incision in the posterior wall either longitudi-
nally to open the entire length of the rectocoele or trans-
versely to produce a broad based flap and expose the
entirety of the rectocoele, or a combination of the two
incisions in the shape of an inverted ‘T’. In most repairs
the redundant rectal wall is plicated outside the bowel
wall. The vaginal wall is then reconstructed with resec-
tion of any excess vaginal mucosa. Many repairs include
some degree of approximation of the levator ani and pel-
vic side wall muscles to formally reinforce the reconstruc-
tion of the rectovaginal septum, although with the
reputed higher risk of dyspareunia. More recently
attempts have been made to localise specific defects in
the rectovaginal septum. This has led to ‘site specific’
repairs [6,7], where the individual defects are repaired
before the vaginal wall is closed. All of these types of
repairs may be augmented by mesh reinforcement, usu-
ally using one of a variety of collagen meshes.
The rectovaginal septum may be entered through a
transperineal route. A transverse or curved incision is
made in the perineal body towards the vagina and the dis-
section extended anterior to the sphincter complex to gain
access to the rectovaginal septum. Having gained expo-
sure, a repair is made in the same way as in a transvaginal
approach. The potential advantage to this route is that it
may be combined with a sphincteroplasty in those women
with a deficient sphincter and a concurrent rectocoele.
Finally, a rectocoele can be considered as a redundant
pocket of rectum, rather than a weakness in the rectovagi-
nal septum leading to herniation of the rectum. A transa-
nal repair addresses the rectal redundancy with either an
anterior Delorme’s style repair (Sarle’s repair [5]) or with
a sutured pexy of the anterior rectal wall (Block repair
[4]). In the former repair, the mucosa is dissected free
from the rectal muscle and excised. Following this, the
rectal muscle coat is plicated longitudinally to obliterate
the rectocoele pocket and the mucosa is re-approximated
to close the defect. In the Block repair, full thickness lon-
gitudinal sutures are placed anteriorly to draw together
the redundant anterior rectal pocket and close the recto-
coele. It is evident that these procedures necessitate a
degree of rectal wall excision or suspension respectively.
Scope
The overall purpose of the CapaCiTY review series is to
assess the efficacy and harms of procedures for chronic
constipation in adults. The focus is therefore directed to
a population presenting with symptoms of obstructed
defecation, rather than women with only prolapse, uri-
nary symptoms or both (see overview and methods
paper). One group of procedures considered beyond
the scope of this systematic review included those where
excision is effected without reinforcement, e.g. rectal
excision only, such as stapled transanal resection of the
rectum (STARR). As is noted above, anterior Delorme’s
or Sarle’s procedures are included, which include a
degree of resection, but also have an significant element
of reinforcement with muscle wall plication (targeted at
the rectovaginal plane), which is not present in pure
resection. This noted, a small number of studies have
specifically focused stapled resection to the obliteration
of a rectocele by anterior deployment of a stapler to
exact mucosal excision (much like stapled haemor-
rhoidopexy). In a sense, these reinforce the RV septum
by tightening tissue and have been included for comple-
tion in this review. Further, most compare this
approach with one of the other approaches also covered
in this review. The separate review covering rectal exci-
sion includes numerous studies of STARR in which the
device is used to excise circumferential full-thickness
excision and the reviews overlap in only one study [8].
Circumferential Delorme’s procedures are excluded
from this review as their focus is not on reinforcement
of the rectovaginal septum but rather on general resec-
tion for prolapse (covered in rectal suspension review).
Studies where outcomes could not be segregated by eli-
gible procedure were also excluded, due to a mixed
patient population with internal and external rectal pro-
lapse, mixed indications including numerous pelvic floor
abnormalities or limited postoperative outcomes.
Previous reviews
There have been no systematic reviews of the results of
rectocoele repair for the treatment of obstructed defae-
cation or constipation. There has been a systematic
Cochrane review (with updates) on the surgical man-
agement of pelvic organ prolapse in women [9–13],
which includes review of posterior vaginal repair for rec-
tocoele. This review included seven randomised trials
on women with posterior vaginal wall prolapse [3,14–
19], three trials comparing vaginal and transanal
approaches [3,14,18]. In addition, another trial pro-
vided data for women with rectocele undergoing poste-
rior repair with and without absorbable mesh [16].
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There has been one systematic review of the use of bio-
logics in urogynaecological repairs [20]. In addition,
the International Continence Society, 5th International
Consultation on Incontinence, Paris, February 2012,
pages 1411–1414 [21], covers posterior repair. Neither
this, nor the Cochrane process focussed on the specific
management of patients with constipation.
Summary of search results and study quality
The search yielded a total of 72 citations for full text
review (Fig. 1). From these, 44 articles published
between 1990 and 2016 contributed 43 studies to the
systematic review (one cohort was spread across two
publications with a focus on perioperative morbidity
[22] and clinical outcomes [23], respectively). Data on
outcomes were provided for a total of 3346 patients
(study mean: 78, range 13–307) (Table 1). Specific
exclusions after full-text review (and after exclusion of
five non-English language publications) included: four
studies where the population sample was confirmed to
be <20 patients; eight studies where follow up was less
than 12 months; two studies of out of scope proce-
dures; four studies where data were considered as dupli-
cate; three studies where outcomes could not be
segregated by eligible procedure; and two studies with
no relevant outcome data.
The quality of studies varied. The 43 included stud-
ies included three randomised controlled trials (RCTs)
and 40 observational studies. The former included one
good quality RCT (level IB) with a low level of suscep-
tibility to bias and two with less well described method-
ology (level IIB). The 40 observational studies included
eight good quality cohort studies with low susceptibility
to bias (level IIB). Other studies were a mix of prospec-
tive and retrospective case series. Mean study follow-up
was 2.1 years (range 0.7–6.2 years); 19 studies origi-
nated from European centres, 12 from the USA and 12
from other countries. The studies covered the full spec-
trum of types of repair and are shown in Fig. 2.
Results
Perioperative data
The 43 studies included 62 patient cohorts receiving one
of eight procedures (Table 2). Perioperative data were
reported inconsistently by studies, with 24 (39%) cohorts
reporting average procedural duration and 29 (47%)
reporting average length of stay (Tables 2 and 3). There
was considerable variation in these measures when com-
paring procedures: design heterogeneity, small numbers
of studies and large range of values precludes any clear
pattern. The overall average duration of procedures was
67 (range 20–169) minutes, and the overall average
length of stay was 3.9 (range 1–15) days.
Summary evidence statements: perioperative data
• The average duration of procedures was about one
hour, although this is inconsistently reported and ran-
ged widely between studies from 20 to 169 min
(level IV).
• The average length of stay was about 4 days although
this is inconsistently reported and ranged widely
between studies from 1 to 15 days (level IV).
• There was inadequate evidence to determine varia-
tions in procedural duration or length of stay by type
of procedure (level IV).
Figure 1 PRISMA diagram of search
results.
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Table 1 All studies included in systematic review.
Authors Year Centre Country N FU (months) Design Grade*
Arnold [24] 1990 Columbus, OH USA 64 24 RCS IV
Janssen [25] 1994 Utrecht Netherlands 76 12 PCS IV
Infantino [26] 1995 Padova Italy 21 24 RCS IV
Murthy [27] 1996 Washington DC USA 33 31 RCS IV
van Dam [22,23]† 1996/2000 Rotterdam Netherlands 75 and 89 14 and 52 PCH IIB
Kahn [18] 1997 London UK 231 72 RCS IV
Khubchandani [28] 1997 Allentown, PA USA 123 38 RCS IV
Cundiff [29] 1998 Durham, NC USA 69 12 RCS IV
Tjandra [30] 1999 Melbourne Australia 59 19 RCH IV
Van Laarhoven [31] 1999 London, St Marks UK 22 27 RCS IV
Boccasanta [32] 2001 Milan‡ Italy 267 24 RCS IV
Lopez [33] 2001 Stockholm Sweden 25 61 PCH IV
Ayabaca [34] 2002 Rome Italy 60 48 RCS IV
Ayav [35] 2004 Nancy France 21 58 RCS IV
Heriot [36] 2004 London UK 45 24 RCS IV
Maher [37] 2004 Brisbane Australia 38 12.5 PCS IV
Mercer-Jones [38] 2004 Newcastle UK 22§ 12.5 PCS IV
Nieminen [14] 2004 Tampere Finland 30 12 RCT IIB
Abramov [7] 2005 Evanston, IL USA 307 12 PCH IIB
Dippolito [39] 2005 Bethlehem, PA USA 13 16 RCS IV
Milani [40] 2005 Milan Italy 63 17 PCS IV
Roman [41] 2005 Rouen France 71 74 RCS IV
Thornton [42] 2005 Sydney Australia 82 44 RCH IIB
Altman [43] 2006 Stockholm Sweden 23 36 PCS IV
Paraiso [15] 2006 Cleveland, OH USA 105 24 RCT IB
Yamana [44] 2006 Tokyo Japan 30 38 PCS IV
Gustilo-Ashby [45] 2007 Cleveland, OH USA 99 12 RCT IIB
Lim [46] 2007 Melbourne Australia 53 36 RCS IV
Puigdollers [47] 2007 Barcelona Spain 35 12 PCS IV
Sardeli [48] 2007 Aarhus Denmark 51 27 RCS IV
Tsujinaka [49] 2007 Chiba Japan 111 12 PCH IIB
Biehl [50] 2008 Atlanta, GA USA 195 13.8 RCS IV
Harris [8] 2009 Orlando, FL USA 73 14 RCH IV
Schwandner [51] 2009 Giessen Germany 102 18 RCS IV
Leal [52] 2010 Teresina Brazil 35 12 PCS IV
Cruz [53] 2011 Brazil Brazil 75 21 PCS IV
Chung [54] 2012 Seoul S Korea 50 12 RCH IIB
Mahmoud [55] 2012 Mansoura Egypt 45 12 PCH IIB
Sung [17] 2012 Providence, RI USA 160 12 PCH IIB
van der Hagen [56] 2012 Stadskanaal Netherlands 27 12 RCS IV
Guzman Rojas [57] 2015 ‡ Australia/Chile 137 16 PCH IIB
Shafik [58] 2015 Cairo Egypt 84 12 PCS IV
Melich [59] 2016 Chicago, IL USA 23 12 PCS IV
N, Number of patients; PCS, Prospective Case Series; PCH, Prospective Cohort Study; RCS, Retrospective Case Series; RCH,
Retrospective Cohort Study; RCT, Randomised Controlled Trial.
*Oxford CEBM [60].
†Same cohort of patients, study from 1996 used for peri-operative data and study from 2000 long term outcome data.
‡Multicentre study.
§Twenty-four patients entered study: two were excluded due to rectal injury and so no mesh implanted.
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Harms
Perioperative complications
Four measures of harm were reported by a majority of
studies within the review: overall complications, bleed-
ing, fistulation and haematoma/sepsis. There was con-
siderable heterogeneity in surgical morbidity, reported
as overall procedural complication rates; with individual
study rates varying from 0% to 61% (see Table 2). This
heterogeneity may have reflected (for example) differ-
ing inclusion, procedural content, context of care, or
thresholds or conventions for recording complications.
Random effects meta-analysis found the overall compli-
cation rate to be 11.5% (95% CI: 7.2–16.6%),
I2 = 87% (Fig. 3). Overall complication rates varied
within and between procedures without evidence to
favour one or more procedures. Although variable, the
bleeding complication rate was generally low being
reported as zero in 50% of cohorts of procedures. Ran-
dom effects meta-analysis found the pooled bleed rate
to be 2.0% (95% CI: 0.7–3.6%), I2 = 68%. The
reported fistulation rate was consistently low (0% in
80% of cohorts). Random effects meta-analysis found
the fistulation rate to be 0.0% (95% CI: 0.0–0.1%),
I2 = 0%. The rate of haematoma or sepsis varied
between studies but was generally low (0% in 56% of
cohorts). Random effects meta-analysis found the
pooled rate of haematoma or sepsis to be 0.9% (95%
CI: 0.2–2.0%), I2 = 54% (Fig. 4). Although there was
some evidence of variation by procedure, sub-group
findings are based on selective reporting of relatively
few and small studies and should be viewed with cau-
tion.
Other measures of short term harm were less consis-
tently reported: perioperative pain (37% of cohorts),
urine retention (6%) and UTIs (10%).
Long term adverse outcomes
Measures of long term harm were poorly reported:
urgency (19%) and anal stenosis (13%). Although 37
cohorts (60%) made some assessment of dyspareunia,
these assessments were not made in an adequately com-
parable fashion. Wide variations between studies may
reflect inconsistency in the studies when reporting
improvement, deterioration or de novo dyspareunia. Rates
of mesh erosion were as high as 30% but were only
reported in two studies [40,46]. This adverse outcome is
devastating for the female sufferer and is rightly receiving
extensive media coverage, focus by some regulatory bod-
ies (e.g. Scottish Government) and much interest by sur-
geons themselves. It is thus unfortunate that in the
narrowly defined context of this systematic review, evi-
dence regarding this outcome was of poor quality.
Summary evidence statements: harms
• Evidence is drawn from observational studies and
comparisons. Most comparisons featured considerable
heterogeneity, which may have multiple causes (level
IV).
• Overall procedural complication rates ranged from 0%
to 61%. However, these complications typically
occurred in about 7–17% of procedures (level IV).
• Post-operative bleeding rates were low, typically rang-
ing from 0% to 4% (level IV).
• Fistulation was a very rare complication, not occur-
ring at all in most studies (level IV).
• Mesh erosion was a common complication, but only
reported in two studies (level IV).
• The occurrence of haematoma or sepsis was typically
low at around 0–2% (level IV).
• Considering measures of harm, there was insufficient
evidence to prefer one type of procedure over another
(level IV).
• Long term adverse outcomes were poorly reported
(level IV).
• Dyspareunia was reported too inconsistently to make
meaningful comparisons between procedures,
although it may be central to patient decision making
(level IV).
• Only two procedure-related deaths were reported for
3209 patients included in studies (level IV).
Efficacy
Most studies used ad hoc questionnaire assessment of
symptoms (n = 27) to assess efficacy; other tools used
included Cleveland Clinic Constipation score (n = 2),
Wexner constipation score (n = 3), obstructed defaeca-
tion score (n = 4) with single studies using the follow-
ing: PAC QOL; Short Form-36 (SF-36); St Mark’s
Figure 2 Venn diagram showing the distribution of studies
between different types of repair. KEY: Box denotes number of
studies in each category. *includes only one Level IB RCT
[15].
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Table 3 Summary of selected data from Table 2.
Procedure
Procedure duration (min) Length of stay (days) Follow-up (months)
N Mean Range N Mean Range N Mean Range
Standard TVR 8 67.6 (35.0–150.0) 9 5.2 (2.0–15.0) 17 22.9 (8.0–72.0)
Site-specific TVR 2 91.8 (32.5–151.0) 2 2.1 (2.0–2.1) 5 18.2 (12.0–27.0)
Block sutured TAR 2 55.1 (30.5–79.6) 3 6.4 (4.5–9.0) 5 22.2 (12.0–27.0)
Delormes/Sarles TAR 3 62.0 (45.0–79.6) 5 3.2 (1.9–4.5) 13 27.2 (12.0–74.0)
Delormes/Sarles TAR + TVR 0 – – – – (0.0–0.0) 1 52.0 –
Stapled transanal resection 5 47.9 (20.0–79.6) 6 2.4 (1.0–4.5) 6 20.4 (8.0–58.0)
Transperineal repair 1 73.4 – 1 5.2 – 3 28.0 (12.0–48.0)
Mesh repair 3 88.0 (39.0–169.0) 3 2.3 (2.0–3.0) 12 19.0 (12.0–36.0)
All procedures 24 66.6 (20.0–169.0) 29 3.9 (1.0–15.0) 62 23.1 (8.0–74.0)
Figure 3 Forest plot showing rates of
total procedural complications
(percentage of patients) by procedure
type. KEY: TVR, transvaginal repair;
TAR, transanal repair; TV, transvaginal;
TP, transperineal.
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incontinence score; Pelvic Floor Distress Inventory-20
(PFDI-20) questionnaire; Pelvic Floor Impact-7 (PFI-
7) questionnaire; Pelvic Organ Prolapse/Urinary Incon-
tinence Sexual Questionnaire (PISQ-12). Global ‘suc-
cess’ or ‘satisfaction’ ratings (GSR) were obtained via a
variety of methods for 47 of the 62 cohorts (where ‘sat-
isfied’ or ‘very satisfied’, ‘good’, ‘very good’ and ‘excel-
lent’ were interpreted as positive outcomes) (Table 4).
Further, some studies also reported individual symp-
toms. No study reported acquiring data objectively
using personnel not involved in the surgical care of the
patient or data collection blind to intervention status
(RCTs were not observer-blinded).
Data were too inconsistently reported to usefully
analyse efficacy outcomes either in their natural units or
after standardisation. Instead a binary response of global
improvement (yes/no) was derived for each cohort of
patients. Reported in 76% of procedures, random effects
meta-analysis found global improvement to be 72.8%
(95% CI: 66.8–78.3%), I2 = 86% (Fig. 5); again there
was considerable heterogeneity between findings. Given
the crudeness and imprecision of estimates, as well as
small numbers of studies/patients for some procedures,
there is insufficient evidence that particular procedures
provide higher levels of improvement.
For individual symptoms, changes in percentage of
patients experiencing each symptom were not reported
for a majority of studies. Straining was reported for
45% of total procedures; incomplete emptying for 47%;
vaginal digitation for 50%. Other symptoms were less
frequently reported. All symptom measures featured
considerable heterogeneity and selective reporting by
(generally) small studies limiting any comparison
between procedures. These caveats accepted, the overall
Figure 4 Forest plot showing rates of
haematoma or sepsis (percentage of
patients) by procedure type. KEY: TVR,
transvaginal repair; TAR, transanal repair;
TV, transvaginal; TP, transperineal.
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Table 4 Percentage success based on global satisfaction ratings and individual recorded symptoms.
Authors Year N FU
Global %
improved
% Reduction in symptom
Straining
Incomplete
empty
Vaginal
digitation
Anal
digitation
Perineal
digitation
(a) Transvaginal repairs (including site specific repair)
Transvaginal
Arnold [24] 1990 29 24 77 NR NR NR NR NR
Infantino [26] 1995 8 36 75 88 75 75 NR NR
Kahn [18] 1997 231 72 NR 11 11 67 77 77
Cundiff [29] 1998 69 12 * 30 NR NR NR NR
Lopez [33] 2001 25 61 NR NR 91 48 NR NR
Maher [37] 2004 38 12.5 97 60 NR 84 NR 84
Nieminen [14] 2004 15 12 93 NR NR 66 66 66
Abramov [7] 2005 183 12 NR 18 NR NR NR NR
Paraiso [15] 2006 37 24 74 32 17 24 NR 24
Yamana [44] 2006 30 38 90 90 60 42 NR NR
Gustilo-Ashby [45] 2007 33 12 48 31 28 34 NR 34
Tsujinaka [49] 2007 40 12 80 NR NR 35 NR 35
Harris [8] 2009 37 8 78 † NR NR NR NR
Schwandner [51] 2009 102 18 70 NR 83 67 NR 67
Chung [54] 2012 24 12 75 NR NR NR NR NR
Sung [17] 2012 81 12 NR 9 30 18 NR 18
Shafik [58] 2015 84 12 94 NR NR NR NR NR
Site specific
Abramov [7] 2005 124 12 NR 20 NR NR NR NR
Paraiso [15] 2006 37 24 88 35 18 37 NR 37
Gustilo-Ashby [45] 2007 37 12 50 31 28 34 NR 34
Sardeli [48] 2007 51 27 NR NR 14 NR NR NR
Guzman Rojas [57] 2015 137 16 85 36 NR NR NR NR
(b) Transanal repairs
Block sutured
Arnold [24] 1990 35 NR 83 80 NR NR NR NR
Infantino [26] 1995 13 24 85 92 77 86 NR NR
Van Laarhoven [31] 1999 7 27 43 NR 0 17 NR NR
Boccasanta [32] 2001 44 24 42 NR NR NR NR NR
Tsujinaka [49] 2007 71 12 83 NR NR 34 NR 34
Stapled
Boccasanta [32] 2001 15 11.3 42 NR NR NR NR NR
Ayav [35] 2004 21 58 76 NR 76 67 NR NR
Harris [8] 2009 36 8 83 † NR NR
Leal [52] 2010 35 12 88 ‡ NR NR NR NR
Cruz [53] 2011 75 21 NR NR NR NR NR NR
Mahmoud [55] 2012 22 12 78 51 45 45 NR NR
Delorme’s style
Janssen [25] 1994 76 12 84 56 41 21 NA NA
Murthy [27] 1996 33 31 62 19 19 NR NR NR
Khubchandani [28] 1997 123 38 82 NR NR NR NR NR
Tjandra [30] 1999 59 19 NR NR 78 39 39 NR
Boccasanta [32] 2001 82 24 42 NR NR NR NR NR
Ayabaca [34] 2002 13 48 69 68 NR NR NR NR
Nieminen [14] 2004 15 12 73 NR NR 39 39 39
Dippolito [39] 2005 13 16 92 NR 86 NR NR NR
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pooled finding for reduction in strain was 38.0% (95%
CI: 27.1–49.6%), I2 = 94%; reduction in incomplete
emptying was 44.4% (95% CI: 30.2–58.9%), I2 = 96%;
and reduction in vaginal digitation was 42.7% (95% CI:
34.9–50.6%), I2 = 86%.
The aim of reinforcing the rectovaginal septum is
to restore normal anatomy which theoretically will
enable normal evacuation. Given the underlying aim of
surgery is to correct anatomy, an assessment of
anatomical recurrence is also important (although this
is necessarily only a surrogate of clinical outcome).
Studies variously and inconsistently reported clinical,
radiological and symptom recurrence (Table 5). Clini-
cal recurrence was reported for 44% of cohorts
(Fig. 6). The overall clinical recurrence rate was 17.1%
(95% CI: 11.7–23.3%), I2 = 89%, with individual
findings for procedures varying from 0% to 55%. There
is a suggestion that site specific TVR features a higher
clinical recurrence rate that other procedures, based on
four studies and 349 patients, although this may be a
chance finding given the selective reporting by studies
(Fig. 6). One study showed that the results of a site
specific repair are further compromised by the concur-
rent use of collagen mesh [15].
Summary evidence statements: efficacy
• Data on efficacy were inconsistently measured and
findings heterogeneous, making estimates tentative
and imprecise (level IV).
• Although inconsistent, assessments of patient global
improvement typically suggest a good outcome in
about 67–78% of patients (level IV).
Table 4 (Continued).
Authors Year N FU
Global %
improved
% Reduction in symptom
Straining
Incomplete
empty
Vaginal
digitation
Anal
digitation
Perineal
digitation
Roman [41] 2005 71 74 29.6 NA 50.7 42.30 42.3 NA
Thornton [42] 2005 40 44 28 NR NR NR NR NR
Puigdollers [47] 2007 11 12 66 52 74 52 NR 52
Chung [54] 2012 26 12 77 NR NR NR NR NR
Mahmoud [55] 2012 23 12 78 51 45 45 NR NR
Combined TV and TA
van Dam [22] 2000 89 52 69 NR NR NR NR NR
(c) Transperineal repairs
Boccasanta [32] 2001 50 24 41 NR NR NR NR NR
Ayabaca [34] 2002 11 48 73 NR NR NR NR NR
Puigdollers [47] 2007 24 12 66 52 74 52 NR 52
(d) Mesh repairs
Mesh
Van Laarhoven [31] 1999 15 27 87 NA 67 47 NA NA
Mercer-Jones [38] 2004 22 12.5 55 30 50 23 NA NA
Milani [40] 2005 63 17 NA NA NA NA NA NA
Altman [43] 2006 23 36 NA 16 6 15 6 NA
Paraiso [15] 2006 31 24 90 27 65 44 NA 44
Gustilo-Ashby [45] 2007 29 12 76 31 28 34 NA 34
Lim [46] 2007 53 36 47 31 NA NA NA NA
Biehl [50] 2008 95 13.8 NA NA NA NA NA NA
Biehl [50] 2008 100 13.8 NA NA NA NA NA NA
Sung [17] 2012 79 12 NA 9.2 30 18 NA 18
van der Hagen [56] 2012 27 12 NA NA NA NA NA NA
Melich [59] 2016 23 12 NA NA NA NA NA NA
Negative values indicate increase in symptoms.
*Global improvement over all studied = 8.6 (scale from 0 to 10).
†ODS score Post 1.86 (no data pre).
‡Cleveland Clinic Constipation score Pre 15.2 vs Post 4.4 (P = 0.001).
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• Findings for global improvement, derived from global
satisfaction rating scales, provide insufficient evidence
to prefer one type of procedure over another (level
IV).
• Other patient symptom scores were inconsistently
reported (level IV).
• Approximately 30–50% of patients may experience
reduced symptoms of straining, incomplete empty-
ing or reduced vaginal digitation (level IV).
• Anatomical recurrence (as judged by a variety of mea-
sures) occurred in approximately 17% patients at
mean follow up of 23.4 months (range 12–74) (level
IV).
Patient selection
Patient selection is generally perceived by experts as impor-
tant when choosing a surgical approach. There was a vast
variation in the preoperative investigation of patients in the
studies. Most studies included evacuation imaging (33 out
of the total 43) where defaecation proctography was used
in all but one (which used isotope imaging) [36]. There
was selective use of anal ultrasound, anorectal physiological
assessment, with colonic transit studies being recorded in
12 studies. There was however little correlation between
the results of surgery and preoperative investigation results.
Key features include the presence of a symptomatic
Figure 5 Forest plot showing rates of
global rating of satisfaction (percentage
of patients) by procedure type. KEY:
TVR, transvaginal repair; TAR, transanal
repair; TV, transvaginal; TP,
transperineal.
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Table 5 Recurrence rates by type of operation
Authors Year N FU
Recurrence rate %
Clinical Radiological Symptoms
(a) Vaginal repairs
Transvaginal
Arnold [24] 1990 29 NR NR NR NR
Infantino [26] 1995 8 36 13 NR NR
Kahn [18] 1997 231 72 11 NR NR
Cundiff [29] 1998 69 12 NR NR NR
Lopez [33] 2001 25 61 NR NR NR
Maher [37] 2004 38 12.5 NR NR NR
Nieminen [14] 2004 15 12 7 7 7
Abramov [7] 2005 183 12 18 NR 4
Paraiso [15] 2006 37 24 25 NR NR
Yamana [44] 2006 30 38 0 3.3 0
Gustilo-Ashby [45] 2007 33 12 NR NR NR
Tsujinaka [49] 2007 40 12 NR NR NR
Harris [8] 2009 37 8 11 NR NR
Schwandner [51] 2009 102 18 NR NR 53
Chung [54] 2012 24 12 NR NR NR
Sung [17] 2012 81 12 39 NR 35
Shafik [58] 2015 84 12 NR NR 6
Site specific
Abramov [7] 2005 124 12 44 NR 11
Paraiso [15] 2006 37 24 40 NR NR
Gustilo-Ashby [45] 2007 37 12 NR NR NR
Sardeli [48] 2007 51 27 41 NR NR
Guzman Rojas [57] 2015 137 16 25 20 34
(b) Transanal repairs
Block suture
Arnold [24] 1990 35 NR NR NR NR
Infantino [26] 1995 13 24 7.6 NR NR
Van Laarhoven [31] 1999 7 27 NR NR NR
Boccasanta [32] 2001 44 24 13 NR 5.9
Tsujinaka [49] 2007 71 12 NR NR NR
Stapled
Boccasanta [32] 2001 15 11.3 13 NR 5.9
Ayav [35] 2004 21 58 NR 57 NR
Harris [8] 2009 36 8 2.7 NR NR
Leal [52] 2010 35 12 NR NR NR
Cruz [53] 2011 75 21 NR 11 NR
Mahmoud [55] 2012 22 12 NR NR NR
Delorme’s style
Janssen [25] 1994 76 12 84 56 41
Murthy [27] 1996 33 31 NR NR NR
Khubchandani [28] 1997 123 38 8.9 NR 8.9
Tjandra [30] 1999 59 19 NR NR 1.7
Boccasanta [32] 2001 82 24 13 NR 5.9
Ayabaca [34] 2002 13 48 NR NR NR
Nieminen [14] 2004 15 12 40 40 33
Dippolito [39] 2005 13 16 92 NR 86
Roman [41] 2005 71 74 29.6 NA 50.7
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rectocoele greater than 2 cm on proctography with evi-
dence of contrast trapping at the end of maximal evacua-
tion. Where graded, generally rectocoeles operated upon
were grade 2 or 3. Only one study measured the rectocoele
clinically with POPQ assessment [37]. Other than medical
co-morbidity precluding surgery there were very few con-
sistent exclusion criteria in any of the studies, although sev-
eral excluded those women with slow transit constipation.
Furthermore, in the few studies that related preoperative
assessment to outcome, none could show an association
between baseline symptoms or size of rectocoele and func-
tional outcome. The need to digitate to assist evacuation
did not appear to predict outcome following surgery, but
may predict the need to digitate postoperatively.
Summary evidence statements: patient selection
• Although patient selection is perceived as vital in pre-
dicting outcome it was inconsistently documented
(level IV).
• There was no evidence to support better outcomes
based on selection of patients with a particular size or
grade of rectocoele (level IV).
Conclusions
A systematic review of evidence for the perioperative
and long terms benefits and harms of recto-vaginal rein-
forcement procedures to treat symptoms of constipation
identified only one high quality study. Two further ran-
domized controlled trials were identified although these
were small and had methodological limitations. The evi-
dence base was therefore characterised almost exclu-
sively by observational studies of variable and often
uncertain methodological quality. Future studies should
provide robust and comparative evidence for clinicians
to support patient decision making, both in terms of
the incremental benefits and harms of procedures.
Table 5 (Continued).
Authors Year N FU
Recurrence rate %
Clinical Radiological Symptoms
Thornton [42] 2005 40 44 NR NR 56
Puigdollers [47] 2007 11 12 NR NR NR
Chung [54] 2012 26 12 NR NR NR
Mahmoud [55] 2012 23 12 NR NR NR
Combined TV and TA
van Dam [22] 2000 89 52 NR NR 29
(c) Transperineal repairs
Boccasanta [32] 2001 50 24 13 11 6.40
Ayabaca [34] 2002 11 48 NR NR NR
Puigdollers [47] 2007 24 12 NR NR NR
Authors Year N FU
Recurrence rate %
Repair type Mesh typeClinical Radiological Symptoms
(d) Mesh repair
Van Laarhoven [31] 1999 15 27 NA NA NA TP/TA Synthetic marlex
Mercer-Jones [38] 2004 24 12.5 4.50 NA NA TP Synthetic prolene/Vipro II
Milani [40] 2005 63 17 NA NA NA TV Synthetic prolene
Altman [43] 2006 23 36 NA NA NA TV Porcine xenograft
Paraiso [15] 2006 31 24 55 NA NA Site specific Porcine xenograft
Gustilo-Ashby [45] 2007 29 12 NA NA NA TV Porcine xenograft
Lim [46] 2007 53 36 22 NA NA TV Synthetic vipro II
Biehl [50] 2008 95 13.8 1 NA NA Site specific Porcine dermal xenograft
Biehl [50] 2008 100 13.8 7 NA 3 Site specific Human dermal allograft
Sung [17] 2012 79 12 38.9 NA 34.8 TV Porcine subintestinal submucosa
van der Hagen [56] 2012 27 12 NA NA NA TV Synthetic prolene
Melich [59] 2016 23 12 4 4 4 TV Porcine dermal xenograft strattice
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Greater understanding is required of the mediating
effects of prognostic factors particularly preoperative
definition of both functional and radiological parame-
ters that impact upon treatment success.
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